SEC Form 4 · accession 0000874015-16-000151
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Lynne Parshall
Officer — COO · Director
Period of report
Dec 15, 2016
Accepted (ET)
Dec 16, 2016 · 7:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2016 | M | 1,000 | $7.25 | A | 1,000 | I | By daughter |
| Common StockF1 | Dec 15, 2016 | S | 1,000 | $50.00 | D | 0 | I | By daughter |
| Common StockF1 | Dec 15, 2016 | M | 1,000 | $7.25 | A | 1,000 | I | By daughter |
| Common StockF1 | Dec 15, 2016 | S | 1,000 | $50.00 | D | 0 | I | By daughter |
| Common StockF1 | Dec 15, 2016 | M | 1,000 | $7.25 | A | 1,000 | I | By son-in-law |
| Common StockF1 | Dec 15, 2016 | S | 1,000 | $50.00 | D | 0 | I | By son-in-law |
| Common StockF1 | Dec 15, 2016 | M | 1,000 | $7.25 | A | 1,000 | I | By grandchild |
| Common StockF1 | Dec 15, 2016 | S | 1,000 | $50.00 | D | 0 | I | By grandchild |
| Common Stock | holding | — | — | — | 16,693 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $7.25 | Dec 15, 2016 | M | 1,000 | D | Jan 3, 2015 | Jan 2, 2019 | Common Stock | 1,000 | 0 | I |
| Employee Stock Option (right to buy) | $7.25 | Dec 15, 2016 | M | 1,000 | D | Jan 3, 2015 | Jan 2, 2019 | Common Stock | 1,000 | 0 | I |
| Employee Stock Option (right to buy) | $7.25 | Dec 15, 2016 | M | 1,000 | D | Jan 3, 2015 | Jan 2, 2019 | Common Stock | 1,000 | 0 | I |
| Employee Stock Option (right to buy) | $7.25 | Dec 15, 2016 | M | 1,000 | D | Jan 3, 2015 | Jan 2, 2019 | Common Stock | 1,000 | 0 | I |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 7/3/2016.